Bioinformatic analysis suggested that 11 genes may contribute to the anti‐tumour effects of hesperidin, including AURKB, BCL6, CASP3, CD80, ghrelin, G6PD, HMOX1, IRF‐7, MMP9, TP53 and (SP1).48 This evidence concerns the gene SP1 and neoplasm.